AB

Aaron Craig Burns

MT Mirati Therapeutics: 14 patents #3 of 63Top 5%
AB Array Biopharma: 4 patents #146 of 335Top 45%
DN Dart Neuroscience: 2 patents #6 of 36Top 20%
Pfizer: 2 patents #2,078 of 5,153Top 45%
📍 San Diego, CA: #2,391 of 23,606 inventorsTop 15%
🗺 California: #32,725 of 386,348 inventorsTop 9%
Overall (All Time): #245,216 of 4,157,543Top 6%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
12421228 Naphthyridine derivatives as PRC2 inhibitors John Michael Ketcham, Matthew Arnold Marx 2025-09-23
12371435 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Nidhi Arora, James Gail Christensen +1 more 2025-07-29
12304915 SOS1 inhibitors Matthew Arnold Marx, John Michael Ketcham, Christopher Ronald Smith, John David Lawson, Xiaolun Wang +2 more 2025-05-20
12252493 Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer Matthew Arnold Marx, John Michael Ketcham 2025-03-18
12006325 Substituted furanopyrimidine compounds as PDE1 inhibitors Brett C. Bookser, Iriny Botrous, DeMichael Chung, Brian Dyck, Andrew Kleinke +5 more 2024-06-11
11964989 KRas G12D inhibitors Xiaolun Wang, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx +21 more 2024-04-23
11702418 SOS1 inhibitors Matthew Arnold Marx, John Michael Ketcham, Christopher Ronald Smith, John David Lawson, Xiaolun Wang +2 more 2023-07-18
11548888 KRas G12C inhibitors Matthew Arnold Marx, James Gail Christensen, Christopher Ronald Smith, John P. Fischer 2023-01-10
11492351 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, John David Lawson +3 more 2022-11-08
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Nidhi Arora, James Gail Christensen +1 more 2022-11-01
11479551 MTA-cooperative PRMT5 inhibitors Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, John David Lawson +3 more 2022-10-25
11453683 KRas G12D inhibitors Xiaolun Wang, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx +21 more 2022-09-27
11434247 Substituted furanopyrimidine compounds as PDE1 inhibitors Brett C. Bookser, Iriny Botrous, DeMichael Chung, Brian Dyck, Andrew Kleinke +5 more 2022-09-06
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Nidhi Arora, James Gail Christensen +1 more 2022-01-11
11091495 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Nidhi Arora, James Gail Christensen +1 more 2021-08-17
10676471 Cycloalkyl-linked diheterocycle derivatives Michael Raymond Collins, Samantha Elizabeth Greasley, Robert Louis Hoffman, Peter Qinhua Huang, Robert Steven Kania +6 more 2020-06-09
10647715 KRas G12C inhibitors Matthew Arnold Marx, Thomas P. Bobinski, John Gaudino, Julia Haas, John Michael Ketcham +5 more 2020-05-12
10125130 Cycloalkyl-linked diheterocycle derivatives Michael Raymond Collins, Samantha Elizabeth Greasley, Robert Louis Hoffman, Peter Qinhua Huang, Robert Steven Kania +6 more 2018-11-13